OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
Recruiting
Observational Study
Cardiogenic Shock
Mechanical Circulatory Support
Cardiogenic Shock Post Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Medical University of Vienna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main goal of this observational, study is to develop a clinical decision support tool utilizing Impella 5.5 pump parameters to predict native heart recovery and prevent adverse events, by leveraging data science and real-world clinical data of cardiogenic shock patients.
Therefore, secondary objectives are essential to consolidating a retrospective longitudinal analysis of Impella 5.5 pump da…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients who were treated for cardiogenic shock and supported with an Impella 5.5 micro-axial flow pump
* Only patients with available high-resolution pump data (downloaded from the clinical console) and ICU digital health record datasets
Exclusion Criteria:
* Patients…
Contacts